InTEST (INTT) Reports Q3 Results; Guides Q4
Tweet
Share
E-mailGet Alerts INTT Hot Sheet
Price: $13.95 +0.22%
Financial Fact:
Engineering and product development expense: 905K
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Engineering and product development expense: 905K
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
InTEST (NASDAQ: INTT) reported Q3 EPS of $0.50, versus $0.17 reported last year. Revenue for the quarter came in at $11.7 million, versus $11.31 million reported last year.
InTEST sees Q4 2011 EPS of $0.03-$0.10. InTEST sees Q4 2011 revenue of $9.5-$10.5 million, versus the consensus of $13.8 million.
InTEST sees Q4 2011 EPS of $0.03-$0.10. InTEST sees Q4 2011 revenue of $9.5-$10.5 million, versus the consensus of $13.8 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ondas Holdings Inc. (ONDS) Misses Q2 EPS by 9c
- Cellebrite DI Ltd. (CLBT) Tops Q2 EPS by 4c ; Offers Guidance
- CorMedix (CRMD) Tops Q2 EPS by 6c; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
